Drug-Eluting Stent Market Analysis, Size, and Share by 2031

The Drug Eluting Stent Market size is expected to reach US$ 12.71 Billion by 2031. The market is anticipated to register a CAGR of 6.9% during 2025-2031.

The report is segmented by Product Type [Polymer-Based Coatings (Non-biodegradable Polymers and Biodegradable Polymers) and Polymer-Free Coatings (Micro porous Surface, Micro structured Surface, Slotted Tubular Surface, and Nanoporous Surface)], Application (Coronary Artery Disease and Peripheral Artery Disease), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)

Purpose of the Report

The report Drug-eluting Stent Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Drug-eluting Stent Market Segmentation Product Type

1. Polymer-Based Coatings
2. Polymer-Free Coatings

Application

1. Coronary Artery Disease
2. Peripheral Artery Disease

Scaffold

1. Cobalt-Chromium
2. Platinum-Chromium
3. Nitinol
4. Others

End User

1. Hospitals
2. Ambulatory Surgical Centers
3. Others

Drug-eluting Stent Market: Strategic Insights

Drug-eluting Stent Market Growth Drivers

1. Rising Cases of Cardiovascular Diseases: The prime driver for the drug-eluting stent market is advancement in cardiovascular diseases. In fact, conditions such as coronary artery disease are increasingly becoming more common, thus fueling a requirement for effective treatments. Drug-eluting stents are increasingly preferred by clinicians when complicated cardiovascular conditions exist primarily for their increased efficacy in the prevention of restenosis and improved patient outcomes.
2. Advancements in Stent Technology: Technological advancements in stents are, therefore an important driver for the growth of the market of drug-eluting stents. Further advancement in design, materials, and mechanisms of drug delivery enhance higher safety and efficacy with fewer complications compared to conventional systems. Better performance of these advanced interventional cardiology solutions further drives this market of drug-eluting stents as clinicians adopt them.
3. Growing Awareness of Treatment Options: Growth in awareness among patients and medical professionals about the therapeutic options available is the primary driver for the drug-eluting stent market. Better education with sufficient availability of information has led to an overall understanding of the benefits and risks involved in the use of drug-eluting stents. Such awareness leads to informed decisions, which in turn further boost the device acceptance rate and increase the growth rate of the market with high patient rates for advanced cardiovascular treatments emerging in the future.

Drug-eluting Stent Market Future Trends

1. Shift Towards Individualized Medicine: One of the notable strides in the overall drug-eluting stents market is the ongoing shift towards, and emphasis on, personalized medicine. Improving treatment outcomes through enhanced stent selection and specific drug formulations based on unique patient traits. As the benefits of genetic profiling and any other patient related aspects continue to gain popularity, the focus of manufacturers has shifted towards the production of drug eluting stents which are tailored to certain heart conditions in a bid to enhance patientsReport Scope

   Drug-eluting Stent Market Regional Insights

   The regional trends and factors influencing the Drug-eluting Stent Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Drug-eluting Stent Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

   Drug-eluting Stent Market Report Scope

   By Application

   • Coronary Artery Disease
   • Peripheral Artery Disease

   By Scaffold

   • Cobalt-Chromium
   • Platinum-Chromium
   • Nitinol
   • Others

   By End User

   • Hospitals
   • Ambulatory Surgical Centers
   • Others

   Europe

   • UK
   • Germany
   • France
   • Russia
   • Italy
   • Rest of Europe

   Asia-Pacific

   • China
   • India
   • Japan
   • Australia
   • Rest of Asia-Pacific

   South and Central America

   • Brazil
   • Argentina
   • Rest of South and Central America

   Middle East and Africa

   • South Africa
   • Saudi Arabia
   • UAE
   • Rest of Middle East and Africa

   Report Attribute	Details
   Market size in 2024	US$ XX Billion
   Market Size by 2031	US$ 12.71 Billion
   Global CAGR (2025 - 2031)	6.9%
   Historical Data	2021-2023
   Forecast period	2025-2031
   Segments Covered	By Product Type Polymer-Based Coatings Polymer-Free Coatings
   Regions and Countries Covered	North America US Canada Mexico
   Market leaders and key company profiles	Boston Scientific Corporation Medtronic, Inc Abbott Laboratories Biosensors International Group Biotronik Lepu Medical Technology Terumo Medical Corporation Cook Medical Shandong JW Medical Systems

   
   

   Drug-eluting Stent Market Players Density: Understanding Its Impact on Business Dynamics

   The Drug-eluting Stent Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

   
   
   
   • Get the Drug-eluting Stent Market top key players overview
   Free Sample PDF